Where Pliant Therapeutics Stands With Analysts
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 12 analysts have published their opinion on Pliant Therapeutics (NASDAQ:PLRX) stock. The analysts have an average price target of $50.5 versus the current price of Pliant Therapeutics at $17.363, implying an upside. The current average has decreased by 1.46% from the previous average price target of $51.25.
October 04, 2023 | 7:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Analysts have a bullish outlook on Pliant Therapeutics (NASDAQ:PLRX) with an average price target of $50.5, implying an upside from the current price of $17.363.
The bullish outlook from analysts suggests that they believe the stock price will increase in the short term. The average price target is significantly higher than the current price, indicating potential for growth. However, the decrease in the average price target could suggest some uncertainty.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100